Applied Biosystems/Amersham
This article was originally published in The Gray Sheet
Executive Summary
Court-mediated settlement concludes patent litigation between the parties with cross-licensing agreement, co-development arrangement for joint development of DNA analysis technologies. An April 2001 summary judgement found that Applied Biosystems sequencing chemistry used with the Prism 3700 DNA analyzer system did not infringe an Amersham patent (1"The Gray Sheet" April 16, 2001, p. 17). A jury trial was set to begin to resolve other infringement claims...